Searle & CO. lifted its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 5.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 46,747 shares of the company’s stock after purchasing an additional 2,300 shares during the period. AbbVie […]